Global Microplate Systems Market is Segmented By Product (Microplate Readers, Microplate Pipetting Systems and Dispensers, Microplate Accessories & Software), By End-User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutes), By Application (Drug Discovery, Clinical Diagnostics, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Microplate Systems Market Overview
[185 Pages] Reportanalyses the global Microplate system market is estimated to reach at a CAGR 10.8% during the forecast period 2023-2030.
The microplate system has become a standard tool in analytical research and clinical diagnostic testing laboratories. A widespread usage is in the enzyme-linked immunosorbent assay (ELISA), the basis of most modern medical diagnostic testing in humans and animals.
Microplate Systems Market Scope
|
Metrics |
Details |
|
Market CAGR |
10.8% |
|
Segments Covered |
By Product, By End-User, By Application, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
For More Insights Download Sample
Microplate Systems Market Dynamics
Increased R&D for new products and the growing need for lab testing for chronic diseases will drive the Microplate Systems Market
Increased R&D will drive the microplate systems market
Many applications use microplate systems, such as pharmaceutical development, life science research , and food safety testing. These instruments and reagents are simple, robust, and well-understood tools that complement advanced technological solutions. Microplate systems have high usage in modern drug discovery and development activities. Increased Research and development in the pharmaceutical industry is evidence of the expenditures. In addition to the choice of a microplate, another key aspect of robust assays in determining the optimal use of microplates. In other words, even with the perfect microplate, assays will only be as robust as the experimental design and processes they are subjected to during an experiment.
Beckman Coulter has received 510(k) clearance from the FDA for its PK7400 Automated Microplate System. Also, the system's reagents have completed FDA approval. Designed for use in blood donor and plasma centers and large reference laboratories, the PK7400 Automated Microplate System offers high throughput for a single analyzer in its class.
The growing need for lab testing for chronic diseases will drive the microplate systems market
The superior specificity and sensitivity associated with the use of molecular assays have improved the field of infectious disease diagnostics by providing clinicians with results that are both accurate and rapidly obtained. The choice of the microplate for an assay depends on various factors, but it all starts with the requirements of the result expected from the assaying process, and the rest is worked out backward.
In virology research, microplate readers are an indispensable tool. Functional methods rely mostly on microplate-based assays and are employed in basic life science research labs and drug screening facilities. Before moving to clinical studies pharmaceutical regulatory agencies suggest using in vitro assays to determine resistance to novel antivirals, cytopathic effects, and mechanisms of action of a virus. Microplate readers deliver robust, reproducible results and can easily be integrated into automated systems which makes them ideal platforms for the setup of high-throughput facilities. During the Corona pandemic methods based on serological testing or the amplification of nucleic acids have gained prominence.
Survival of small key players and disadvantages associated with the device will hamper the market
Huge investments are required for the research and development of new products. Small companies have to invest heavy amounts, which is not possible and make it difficult for the companies to survive in the market.
The main disadvantage of filter-based microplate readers is that they require a different filter for each wavelength needed, reducing flexibility and making it impossible to perform wavelength scans. The drawbacks of monochromator-based microplate readers include overall cost and sensitivity limitations. The inherent design of the diffraction gratings causes significant loss of light both to and from the sample, due to which the overall sensitivity is decreased.
COVID-19 Impact on Microplate Systems Market
The automated and standardized repetitive steps around the development and performance of in vitro microplate assays. Research offering various technologies and system solutions will help develop new treatments and vaccines against COVID-19 faster. Hence, microplate systems will see a rise in their market.
Microplate Systems Market Segmentation Analysis
The microplate reader segment will dominate the microplate systems market
The widely-used instrument microplate reader allows for many samples to be simultaneously measured as if many miniscule experiments were being performed simultaneously. This instrument is used in conjunction with multiwell plates, like the 96 well plates. Microplate readers are long-lived and relatively maintenance-free. Lamps, which last approximately seven years with daily use, are the most vulnerable components. Many microplate readers use LED lamps instead of traditional tungsten lamps. LEDs are maintenance-free, have a significantly longer life than Microplate Readers lamps, and use less energy.
The absorbance microplate readers SpectraMax ABS and ABS Plus, provide sensitivity, convenience, and flexibility for a wide range of assays such as ELISAs, protein quantitation and microbial growth. Both readers feature an 8-channel read head for fast reads, and a subset features patented PathCheck™ Sensor. The temperature-independent PathCheck sensor automatically normalizes and ensures accurate absorbance values by detecting pipetting errors. Combined with a wide application base, industry-leading SoftMax® Pro Software, and validation tools, these readers fit in every lab and every budget.
The drug discovery segment dominated the market
The process throughwhich potential new medicines are identified is known as drug discovery. Drug discovery involves a wide range of scientific disciplines that include biology, pharmacology, and chemistry.
In automating the detection and analysis of labeled or label-free components in microplates during assays or live-cell monitoring microplate readers are used. They are generally distinguished by their mode of detection. Types include luminescence, absorbance, fluorescence polarization, fluorescence intensity and multimode microplate readers. By reading multiple wells simultaneously, microplate readers deliver a high throughput of samples, with the most commonly used 96-well format. As a result, microplate readers are often used in drug discovery.
Biotechnology and pharmaceutical companies held the largest share in this segment
Increased funding by the government for R&D and major companies involving will drive the market in this segment.
Microplate instrumentation is used to determine enzyme activity and gene expression in specific patients so that personalized medications and drug regimens can be created that work better within an individual's body than the traditional therapies would have worked. By reading multiple wells simultaneously, microplate readers deliver a high throughput of samples as a result, they are often used in the drug discovery, bioassays, research, and pharmaceutical industries for screening applications. They are used extensively in the pharmaceutical industry for high-throughput drug screening and biology labs for enzyme assays, immunoassays, binding assays, protein and cell assays, ELISAs, and biomolecule concentration measurements.
Global Microplate Systems Market Geographical Share
North America region will dominate the microplate systems market
Increasing advanced technologies, government initiatives for cell-based research, and increasing focus on drug development will drive the market in this region.
Beckman Colter has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its PK7400 Automated Microplate System, and the system's reagents have completed FDA approval. Designed for use in blood donor and plasma centers, as well as large reference laboratories, the PK7400 Automated Microplate System offers the industry's highest throughput for a single analyzer in its class. It is now available in countries across Canada and the United States. According to the AABB (formerly the American Association of Blood Banks), an estimated 33,000 units are needed to meet patient needs each day. However, the organization also stated, more than 4,000 blood donation events have been cancelled due to the COVID-19 pandemic. Considered as a share of GDP, research and development (R&D) spending was highest in North America.
Microplate Systems Market Players and Competitive Landscape
Major key players microplate systems market are beckman coulter life sciences, BioTek, Danaher, PerkinElmer, Tecan, Thermo Fisher, BMG LABTECH, BERTHOLD, Agilent, Bio-Rad, Promega, Biochrom, Corning, Lonza, Rayto, Mindray, Zhengzhou YKinspection Enterprise Co., Ltd., Chongqing Xishan Science & Technology Co., Ltd, Guangzhou Lety Medical Limited
Beckman coulter life sciences
Overview: Beckman Coulter as a company is committed to advanced healthcare for every individual by applying the power of technology, science and the passion, creativity of their teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Their diagnostic systems are used in complex biomedical testing and are found around the globe in reference laboratories, hospitals, and physician office settings. The company offers a unique combination of people, processes, and solutions designed to elevate the performance of clinical laboratories and healthcare networks.They do this by accelerating care with a menu that matters, bringing the benefit of automation to all, delivering greater insights through clinical informatics, and unlocking hidden value through performance partnership. An operating company of Danaher Corporation since 2011, Beckman Coulter is headquartered in Brea, Calif., and has more than 11,000 global associates working diligently to make the world a healthier place.
Product Portfolio: The company works on Laboratory Systems, CE, Lab Automation, Immunoassay, Hematology, Information Systems, Integrated Systems, Diagnostics, Chemistry, Microbiology, Clinical Informatics, Lab 2.0, Urinalysis, Automation, Clinical Chemistry, In-vitro Diagnostics, Sepsis Diagnosis and Management, Medical Devices, Analyzers, and Core Laboratory.
Key Development: On july 22, 2020 — Beckman Coulter announced that it had received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its PK7400 Automated Microplate System, and the system’s reagents have completed FDA approval. Designed for use in blood donor and plasma centers, as well as large reference laboratories.
